Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia

Clinical trial NCT02340780 · COMPLETED

Trial details

NCT number: NCT02340780
Sponsor: Canadian Cancer Trials Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2015-04-27
Primary completion: 2018-11-21
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.